Receive The Newest Study Notifications

--CStone Pharmaceuticals ("CStone"; HKEX: 2616) today announced that China's National Medical Products Administration (NMPA) has approved the clinical trial application to begin a Phase 1 trial in China for BLU-667 (CS3009), a highly selective and potent RET inhibitor...

-- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), developer of the M-001 universal influenza vaccine candidate, reported today that all participants have completed their final visit in a Phase 2 clinical trial conducted by several Vaccine Treatment and Evaluation Units...

Sanofi, Lead Pharma’s collaborative partner in the development of SAR441169, successfully initiated first human dosing with this novel RORγt Inverse Agonist candidate treatment For Lead Pharma this represents a fourth payable milestone in the SAR441169 collaboration...

Unique Mechanism of Action Suppresses Inflammation and Immune Activation Without Promoting Pro-Inflammatory Lymphocyte Stimulation Preliminary Phase 1 Data Read-outs Anticipated Q3 and Q4 2019 Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on...

First patients treated in a Phase I study with CyPep-1 as an investigational therapy for benign, HPV-induced cutaneous tumors (warts) Novel targeted lytic mechanism offers broad application for multiple indications Further clinical trial in malignant tumors to start...

Late-Breaking Trial Results Presented at European Heart Rhythm Association Annual Congress, ACC Scientific Sessions, and Published in The New England Journal of Medicine WRAP-IT Is the Largest Randomized Global Trial Ever Conducted with Cardiac Implanted Electronic...

I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases, today announced dosing of the first healthy subject in a Phase 1 trial in the...

Presentation at American College of Cardiology shows TAVR outcomes equivalent to surgery, Hoag among clinical trial sites The Jeffrey M. Carlton Heart & Vascular Institute at Hoag, the largest volume cardiovascular program in Orange County, was the first hospital...

Early and frequent patient engagement in a clinical trial is instrumental in the launch of new medical products today. Learn how patient insights improves all aspects of clinical trials, from design to feasibility, from experts in clinical operations. Early engagement...

ExThera Medical Corporation (ExThera) today announced Dr. Stefan Büttner, a senior staff member of the Department of Nephrology, Dialysis and Kidney Transplantation at University Hospital Frankfurt, will present on his clinical experience with the ExThera’s...

Fractyl Laboratories Inc. (Fractyl) today announced the hiring of Margaret Borys as Chief Commercial Officer (CCO) and Juan Carlos Lopez-Talavera, M.D., Ph.D., as Chief Medical Officer (CMO). These additions come as Fractyl is preparing for commercialization efforts...

ReCor Medical, Inc. ("ReCor") announced the 6 month "on-medication" results from its RADIANCE-HTN SOLO clinical trial with simultaneous publication in Circulation, and the first randomization of patients in its RADIANCE-II pivotal trial of its Paradise® Renal...

Health Canada is conducting a safety review after issues were discovered during a clinical trial involving rheumatoid arthritis patients being treated with the drug tofacitinib (sold in Canada under the brand names Xeljanz and Xeljanz XR). Tofacitinib is a...

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announces the enrollment of the 60th patient in its Phase 2 double blind, placebo controlled clinical...

New data showcasing performance of recently acquired RF balloon-based, single-shot ablation technology Boston Scientific Corporation (NYSE: BSX) announced data from the AF-FICIENT I study during a late-breaking clinical trial session today at EHRA 2019, the annual...

TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Clinipace has selected TransPerfect's Trial Interactive E-Feasibility and eTMF...

 Innovate Biopharmaceuticals, Inc. (“Innovate” or the “Company”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced that on March 17, 2019, it entered into an agreement (the...

-Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases...

Study will evaluate safety, tolerability and functional improvement in subjects with severe Alzheimer's disease Results expected in the second half of 2020 Alkahest, Inc., a clinical-stage biotechnology company focused on developing transformative therapies to...

 Allergy Therapeutics plc  (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announced top-line results from the Phase III clinical trial B301of its new adjuvanted birch allergoid product. The trial did not show...